Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
Su Won LeeJin Kwan ChoiYee Ran LyuWon-Kyung YangSeung-Hyung KimJe Hyun KimSi Yeon KimWeechang KangIn-Chul JungBeom Joon LeeJun Yong ChoiTaesoo KimYang-Chun ParkPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
. The aim of this study is to investigate the efficacy and safety of BJIGT in the treatment of PAR and to determine the suitable dosage of BJIGT. Therefore, we planned a randomized, controlled, phase II trial of two different doses of BJIGT compared with placebo, and the results of this study are expected to provide evidence for the use of BJIGT as a treatment of PAR. Trial Registration. The National Clinical Trial Registry Clinical Research Information Service, CRIS, KCT0006616, https://cris.nih.go.kr/cris/search/detailSearch.do/20706.